Medicure Inc (MCUJF) 4.6427 $MCUJF Medicure Reports

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medicure Inc (MCUJF) 4.6427 $MCUJF

Medicure Reports First Quarter 2016 Financial Results
PR Newswire - Wed May 11, 4:00PM CDT
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the quarter ended March 31, 2016.
MPH.VN: 6.260 (-0.290)

Medicure Files Application for New AGGRASTAT® Product Format
CNW Group - Wed May 11, 7:00AM CDT
Expects to Launch Bolus Vial in Q3 2016
MPH.VN: 6.260 (-0.290)

Medicure Announces Departure of President and Chief Operating Officer
PR Newswire - Mon May 09, 6:00PM CDT
Medicure Inc. ("Medicure" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company today announced that the employment agreement with President and Chief Operating Officer, Dawson Reimer, has been terminated, effective immediately. "I and the entire Board of Directors thank Dawson for his commitment and dedication throughout his years of service with Medicure. We wish him all the best in his new endeavours," said Dr. Albert Friesen, Board Chair and CEO of Medicure Inc.
MPH.VN: 6.260 (-0.290)

Medicure to Announce Q1 2016 Financial Results on May 11, 2016
PR Newswire - Wed May 04, 6:00PM CDT
Medicure Inc. ("Medicure" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, will release financial results for the first quarter ended March 31, 2016 after market close on Wednesday, May 11, 2016. Medicure will hold a conference call and webcast regarding the results on Thursday, May 12 2016, at 7:30 AM Central Time (8:30 AM Eastern Time).
MPH.VN: 6.260 (-0.290)

Medicure Announces Grant of Options
CNW Group - Thu Apr 07, 3:25PM CDT
Medicure Inc. (the "Company" (TSXV:MPH, OTCQB:MCUJF) announces today that its Board of Directors has approved the grant of an aggregate of 265,025 options to certain directors, officers, employees, management company employees and consultants of the Company pursuant to the Company's Stock Option Plan. Of these options, 225,025 are set to expire on the fifth anniversary of the date of grant and 40,000 are set to expire on the first anniversary of the date of grant. All of the options were issued at an exercise price of $6.16 per share. The options are subject to the approval of the TSX Venture Exchange.
MPH.VN: 6.260 (-0.290)

Medicure Announces Upcoming Conference Presentations
CNW Group - Tue Apr 05, 8:00AM CDT
Medicure Inc. ("Medicure" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, will be participating and presenting at the following investor conferences in April and May, 2016;
MPH.VN: 6.260 (-0.290)

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015
PR Newswire - Wed Mar 30, 4:00PM CDT
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the year ended December 31, 2015.
MPH.VN: 6.260 (-0.290)

Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016
CNW Group - Wed Mar 23, 4:00PM CDT
Medicure Inc. ("Medicure" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, will release financial results for the fourth quarter and fiscal year ended December 31, 2015 after market close on Wednesday, March 30, 2016. Medicure will hold a conference call and webcast regarding the results on Thursday, March 31 2016, at 7:30 AM Central Time (8:30 AM Eastern Time).
MPH.VN: 6.260 (-0.290)

Medicure to present at Cantech Investment Conference
PR Newswire - Thu Jan 21, 10:44AM CST
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that it will present at the 2016 Cantech Investment Conference on January 26th in Toronto.
MPH.VN: 6.260 (-0.290)

Medicure Announces Preliminary Revenue For Fiscal 2015
PR Newswire - Mon Jan 11, 8:30AM CST
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today reported unaudited net revenue for the 2015 fourth quarter and full fiscal year. All amounts referenced herein are in Canadian dollars.
MPH.VN: 6.260 (-0.290)

Medicure announces ANDA collaboration with Apicore
PR Newswire - Wed Jan 06, 7:00AM CST
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that the Company has initiated the development of a high-value cardiovascular generic drug. The project is a collaboration between Medicure International, Inc. (a wholly owned subsidiary of Medicure Inc.) and Apicore US LLC (together with its affiliates "Apicore", a leading-edge manufacturer of generic active pharmaceutical ingredients ("API's".
MPH.VN: 6.260 (-0.290)

Medicure Announces PDUFA Action Date for New Aggrastat Indication
PR Newswire - Wed Dec 02, 9:48AM CST
Medicure Inc. ("Medicure" or the "Company" (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration ("FDA" has assigned a Prescription Drug User Fee Act ("PDUFA" action date of July 10, 2016, for completing its review of the AGGRASTAT (tirofiban HCl) supplemental New Drug Application ("sNDA" submitted by the Company. The filing of the sNDA was previously announced on September 10, 2015. If approved, the indication statement for AGGRASTAT would be expanded to include the treatment of patients presenting with ST segment elevation myocardial infarction (STEMI) intended for percutaneous coronary intervention (PCI).
MPH.VN: 6.260 (-0.290)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 30

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 28

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 17

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 12

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 15

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 30

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 27

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Navigating Battery Compliance for AI Data Centers

Updated Category News Views 22

Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 40

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading

Top 5 Most Recently Viewed Articles

Raytron's Innovative OGI Cameras Enhance Ozone Layer Protection

Updated Category News Views 194

Raytron's Commitment to Ozone Layer Preservation As the International Day for the Preservation of the Ozone Layer approaches, global attention focuses on looming threats to atmospheric recovery, particularly from greenhouse gases that continue to pose significant risks. While advancements have been made to eliminate CFCs under the Montreal Protocol, the ongoing rise in...

Continue Reading
Stocks Plunge Amid Weak Manufacturing Data and Concerns

Updated Category News Views 122

Market Overview and Reaction to Manufacturing Data In recent trading sessions, US stock indexes have experienced a notable decline, primarily due to disappointing manufacturing data that has raised concerns about the economy's health. The ISM Manufacturing index fell short of expectations, prompting investors to reevaluate their outlook as they prepare for the upcoming...

Continue Reading
Hisense Unveils Vision for a Brighter Future at CES 2026

Updated Category News Views 271

Hisense Showcases Human-Centric Technology at CES 2026 QINGDAO, China — Hisense, a prominent brand in consumer electronics and home appliances, is set to present its exciting vision at CES 2026. This year, Hisense aims to highlight a theme that resonates deeply with audiences: "Innovating A Brighter Life." This theme represents not just a slogan but a commitment to...

Continue Reading
Gilat's Recent Orders Highlight Demand for Satellite Solutions

Updated Category News Views 140

Gilat's Significant Orders for Satellite Technologies Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) has made headlines with a remarkable achievement, securing over $25 million in orders from top-tier satellite operators worldwide. These orders underscore the growing demand for advanced satellite communications solutions, particularly in the rapidly expanding...

Continue Reading
Q.E.P. Co., Inc. Achieves Notable Financial Results in 2025

Updated Category News Views 259

Q.E.P. Co., Inc. Reports Impressive Fiscal 2025 Results Q.E.P. CO., INC. (OTCQX: QEPC) has shared its financial results for the fiscal year ending on February 28, 2025. This marks a significant moment for the Company following a comprehensive portfolio transformation initiated last year, which involved divesting from its Harris Flooring Group and international operations....

Continue Reading